Infection-related Deaths Were Reported With The Use Of Mabcampath (alemtuzumab) Following Initial Combination Therapy With Anti-leukemia Drugs Which Also Suppress The Body's Immune Response - Notice
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2008-11-21
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/ab099dcc-1665-44af-afb2-ed639f9d55e1